Abstract:AbsractObjectives In utero exposure to high levels of endogenous estrogens has been hypothesized to increase breast cancer risk in later life. A high intake of soy has been suggested to protect against breast cancer. We examined the hypothesis that maternal soy intake may be inversely associated with pregnancy hormone levels. Methods The concentrations of hormones (estradiol, estriol, and testosterone) and isoflavones (genistein, deidzein, and equol) were measured in the maternal urine and serum, and umbilical… Show more
“…Plasma concentrations of 50e800 ng/ml have been found for GEN in adults who consume modest amounts of soy foods Setchell and Cole, 2003). Thus, fetus can be actively exposed to GEN by mothers who consume soy products during pregnancy since a high correlation has been observed for isoflavone serum levels between maternal and umbilical cord blood samples, indicating that GEN can be easily transferred to the fetus by placenta (Nagata et al, 2006). This isoflavone is often categorized as a phytoestrogen because of its ability to bind to estrogen receptors (ERs) but display weak estrogenic activity when compared to the estrogen (Vitale et al, 2013).…”
“…Plasma concentrations of 50e800 ng/ml have been found for GEN in adults who consume modest amounts of soy foods Setchell and Cole, 2003). Thus, fetus can be actively exposed to GEN by mothers who consume soy products during pregnancy since a high correlation has been observed for isoflavone serum levels between maternal and umbilical cord blood samples, indicating that GEN can be easily transferred to the fetus by placenta (Nagata et al, 2006). This isoflavone is often categorized as a phytoestrogen because of its ability to bind to estrogen receptors (ERs) but display weak estrogenic activity when compared to the estrogen (Vitale et al, 2013).…”
“…Multiple maternal factors including age, BMI, psychological status, dietary and nutriment intake, and medication use are all associated with hormone levels during gestation [53], [68], [69], [70]. Several epidemiological studies that focused on the effects of endocrine disrupting substances have shown that toxicants exposure such as polybromodiphenyl ethers and phthalates may affect hormone levels of pregnant women and neonates [71], [72], [73].…”
BackgroundNonylphenol (NP) has been proven as an endocrine disrupter and had the ability to interfere with the endocrine system. Though the health effects of NP on pregnant women and their fetuses are sustained, these negative associations related to the mechanisms of regulation for estrogen during pregnancy need to be further clarified. The objective of this study is to explore the association between maternal NP and hormonal levels, such as estradiol, testosterone, luteinizing hormone (LH) and follicle stimulating hormone (FSH), and progesterone.MethodsA pregnant women cohort was established in North Taiwan between March and December 2010. Maternal urine and blood samples from the first, second, and third trimesters of gestation were collected. Urinary NP concentration was measured by high-performance liquid chromatography coupled with fluorescent detection. A mixed-effects model using a generalised estimating equation (GEE) was applied to assess the associations between maternal NP concentration and plasma hormones throughout the three trimesters.ResultsIn total, 162 singleton pregnant women completed this study through delivery. The geometric mean of creatinine-adjusted urinary NP concentrations were 4.27, 4.21, and 4.10 µg/g cre. in the first, second, and third trimesters respectively. A natural log-transformation of urinary NP concentrations were significantly associated with LH in the GEE model (β = −0.23 mIU/ml, p<0.01).ConclusionThis perspective cohort study demonstrates that negative association occurs between maternal NP exposure and plasma LH levels. The estrogen-mimic effect of NP might influence the negative feedback on LH during pregnancy.
“…The detection rates of phytoestrogens, genistein, daidzein and equol in the umbilical cord of the newborns were 100%, 80% and 35%, respectively [46]. Within this perspective, Nagata et al [47] also showed high correlations to isoflavone levels between samples of maternal and umbilical cord blood of 194 accompanied women during pregnancy [47].…”
Section: Soy and Metabolic Programmingmentioning
confidence: 97%
“…In the context of this discussion, it is important to emphasize the ability of placental transfer of phytoestrogens from mother to fetus [46,47]. In this sense, 51 Japanese mothers were accompanied by the time of cesarean section, where we collected serum sample of the mother and the umbilical cord.…”
The consumption of soybeans and their constituents, isolated soy protein and isoflavones, has been associated with positive effects on body weight, lipid profile and insulin, which has stimulated the production and consumption of foods derived from soy. However, these polyphenolic compounds (isoflavones) have similar structure to 17-β estradiol and may act as agonists or antagonists in estrogen receptors. Due to its estrogenic activity, the safety of its consumption during critical periods of development, such as gestation and lactation, has been questioned. Studies that evaluate the effects of soybeans on endocrine metabolic parameters are still controversial. This review focuses on the role that soy and isoflavones play during critical periods of development and into adulthood.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.